SS
ALNY icon

Sunbelt Securities’s Alnylam Pharmaceuticals ALNY Stock Holding History

Sunbelt Securities’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.95K Buy
21
+6
+40% +$2.04K ﹤0.01% 1583
2025
Q4 		$5.96K Hold
15
– – ﹤0.01% 1580
2025
Q3 		$6.84K Hold
15
– – ﹤0.01% 1541
2025
Q2 		$3.53K Hold
15
– – ﹤0.01% 1517
2025
Q1 		$4.05K Hold
15
– – ﹤0.01% 1462
2024
Q4 		$3.54K Hold
15
– – ﹤0.01% 1517
2024
Q3 		$4.13K Hold
15
– – ﹤0.01% 1482
2024
Q2 		$3.65K Hold
15
– – ﹤0.01% 1452
2024
Q1 		$2.24K Hold
15
– – ﹤0.01% 1505
2023
Q4 		$2.87K Hold
15
– – ﹤0.01% 1402
2023
Q3 		$2.66K Hold
15
– – ﹤0.01% 1432
2023
Q2 		$2.85K Sell
15
-3
-17% -$595 ﹤0.01% 1408
2023
Q1 		$3.51K Buy
+18
New +$3.78K ﹤0.01% 1359

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sunbelt Securities's ALNY Position: Q1 2026 in Review

Sunbelt Securities increased its Alnylam Pharmaceuticals (ALNY) stake by 40% in Q1 2026, buying an estimated $2.04K and bringing the position to 21 shares worth $6.95K. The position accounts for ﹤0.01% of the portfolio, ranked #1583.

Sunbelt Securities first reported a position in ALNY in Q1 2023 and has held it in 13 quarters since. 793 funds tracked by Wall St. Rank hold ALNY as of Q1 2026.

  • Sunbelt Securities held 21 shares of Alnylam Pharmaceuticals worth $6.95K as of Q1 2026.
  • Sunbelt Securities bought 6 Alnylam Pharmaceuticals shares in Q1 2026, an estimated $2.04K.
  • Alnylam Pharmaceuticals made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #1583 holding.
  • Sunbelt Securities first reported a position in Alnylam Pharmaceuticals in Q1 2023 and has held it in 13 quarters since.
  • 793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.